In the bidding for the aspirin oral immediate-release formulation (excluding dispersible tablets) (<300mg), a total of 7 companies are proposed to win the bid, in order: Zhejiang Jingxin Pharmaceutical, Nanjing Daoqun Pharmaceutical, Zhejiang Meidishen, CSPC PHARMA, Cisen Pharmaceutical, Chongqing Yaoyou, and Wuhan Jichuang Pharmaceutical. Among them, Zhejiang Jingxin Pharmaceutical's quoted price is 0.034 yuan/piece (specification of 100mg), approximately an 83% reduction from the limit price of 0.2 yuan/piece. (Financial Associated Press reporters Lu Afeng and He Fan)
- Latest
- Detail
阿司匹林口服常释剂型14进7 京新药业拟第一顺位中标
Aspirin oral immediate-release formulation 14 wins the first bid by Zhejiang Jingxin Pharmaceutical.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.